Use of intrathecal baclofen administered by programmable infusion pumps in resistent spasticity.

J. Broseta, F. Morales, G. García-March, M. J. Sánchez-Ledesma, J. Anaya, J. Gonzalez-Darder, J. Barberá

Resultado de la investigación: Contribución a una revistaArtículorevisión exhaustiva

27 Citas (Scopus)


On the basis of previous experimental and clinical studies patients with severe spasticity due to spinal cord damage from multiple sclerosis in 8 cases and postraumatic paraplegia in 6 and resistent to all conservative treatments were selected for a trial with morphine and baclofen administered intrathecally through a catheter placed in the spinal subarachnoid space rostral to the affected segments and attached to a subcutaneous reservoir. Whereas morphine single injection did not show any benefit, baclofen bolus injection 30 to 60 micrograms, revealed a marked decrease of spasticity and associated symptoms in 8 cases. After checking the clinical effect during 3 weeks and changes in electroneurophysiological studies and bladder manometry the catheter was attached to a subcutaneous programmable pump able to be refilled percutaneously and administered baclofen continuously or more often following a multistep complex programme in total doses of 90 to 150 micrograms per day. After a mean follow-up of 5 months all cases showed an absence of spasms and pain, a notable improvement for bettering of sphincter functions and a marked muscle relaxation that improves motor capacity, leading to increased ambulation or mobility. Neither complications nor side-effects were observed.

Idioma originalInglés estadounidense
Páginas (desde-hasta)39-45
Número de páginas7
PublicaciónActa neurochirurgica. Supplementum
EstadoPublicada - 1989
Publicado de forma externa

Áreas temáticas de ASJC Scopus

  • Cirugía
  • Neurología clínica


Profundice en los temas de investigación de 'Use of intrathecal baclofen administered by programmable infusion pumps in resistent spasticity.'. En conjunto forman una huella única.

Citar esto